1. Fleming S (1998) Genetics of kidney tumours. Forum (Genova) 8: 176-184.

2. Brieger J, Weidt EJ, Schirmacher P, Storkel S, Huber C and Decker HJ (1999) Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: an in vivo study on 29 tumors. J Mol Med 77: 505-510.

3. Takahashi A, Sasaki H, Kim SJ, Kakizoe T, Miyao N, Sugimura T, Terada M and Tsukamoto T (1999) Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique. Biochem Biophys Res Commun 257: 855-859.

4. Ishikawa J, Maeda S, Umezu K, Sugiyama T and Kamidono S (1990) Amplification and overexpression of the epidermal growth factor receptor gene in human renal-cell carcinoma. Int J Cancer 45: 1018-1021.

5. Moch H, Sauter G, Gasser TC, Bubendorf L, Richter J, Presti JC, Jr Waldman FM and Mihatsch MJ (1998) EGF-r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization. J Pathol 184: 424-429.

6. Lager DJ, Slagel DD and Palechek PL (1994) The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma. Mod Pathol 7: 544-548.

7. Drabkin HA, Bradley C, Hart I, Bleskan J, Li FP and Patterson D (1985) Translocation of c-myc in the hereditary renal cell carcinoma associated with a t(3;8)(p14.2;q24.13) chromosomal translocation. Proc Natl Acad Sci USA 82: 6980-6984.

8. Yao M, Shuin T, Misaki H and Kubota Y (1988) Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer. Cancer Res 48:6753-6757.

9. Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP and Sauter G (1999) High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 154: 981-986.

10. Perou CM, S0rlie T, Eisen MB, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.

11. Van't Veer LJ and De Jong D (2002) The microarray way to tailored cancer treatment. Nat Med 8: 13-14.

12. Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8: 816-824.

13. Luo J, Duggan DJ, Chen Y, Sauvageot J, Ewing CM, Bittner ML, Trent JM and Isaacs WB (2001) Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res 61: 4683-4688.

14. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB and Teh BT (2001) Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci USA 98: 9754-9759.

15. Rickman DS, Bobek MP, Misek DE, Kuick R, Blaivas M, Kurnit DM, Taylor J, Hanash SM (2001) Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 61: 6885-6891.

16. Alizadeh AA, Eisen MB, Davis RE, et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511.

17. Armstrong SA, Staunton JE, Silverman LB et al. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30: 41-47.

18. Bertucci F, Salas S, Eysteries S, et al. (2004) Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23: 1377-1391.

19. Sültmann H, von Heydebreck A, Huber W, et al. (2005) Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival. Clin Cancer Res 11(2): 646-655.

20. Huber W, Von Heydebreck A, Sultmann H, Poustka A and Vingron M (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18(Suppl 1): S96-S104.

21. Tibshirani R, Hastie T, Narasimhan B and Chu G (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 99: 6567-6572.

22. Vapnik V (1999) The Nature of Statistical Learning Theory: Springer Verlag, Berlin.

23. Breiman L (2001) Random forests. Machine Learn J 45: 5-32.

24. Hromas R, Broxmeyer HE, Kim C, Nakshatri H, Christopherson K, 2nd Azam M and Hou YH (1999) Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem Biophys Res Commun 255: 703-706.

25. Frederick MJ, Henderson Y, Xu X, Deavers MT, Sahin AA, Wu H, Lewis DE, El-Naggar AK and Clayman GL (2000) In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol 156: 1937-1950.

26. Weinschenk T, Gouttefangeas C, Schirle M, et al. (2002) Integrated functional genomics approach for the design of patient-individual antitumor vaccines. Cancer Res 62: 5818-5827.

27. Morimoto I, Sasaki Y, Ishida S, Imai K, Tokino T (2002) Identification of the osteopontin gene as a direct target of TP53. Genes Chromosomes Cancer 33: 270-278.

28. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D and Yeatman TJ (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94: 513-521.

29. Steinberg P, Storkel S, Oesch F and Thoenes W (1992) Carbohydrate metabolism in human renal clear cell carcinomas. Lab Invest 67: 506-511.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment